Allspring Global Investments Holdings LLC Sells 532,697 Shares of Astera Labs, Inc. $ALAB

Allspring Global Investments Holdings LLC lessened its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 96.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,747 shares of the company’s stock after selling 532,697 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Astera Labs were worth $2,312,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of ALAB. Independent Financial Group LLC bought a new stake in Astera Labs in the 1st quarter valued at $1,419,000. Wealthfront Advisers LLC increased its stake in Astera Labs by 100.8% in the first quarter. Wealthfront Advisers LLC now owns 2,663 shares of the company’s stock valued at $292,000 after acquiring an additional 1,337 shares during the period. D.A. Davidson & CO. increased its stake in Astera Labs by 8.5% in the first quarter. D.A. Davidson & CO. now owns 4,064 shares of the company’s stock valued at $445,000 after acquiring an additional 320 shares during the period. Illinois Municipal Retirement Fund raised its position in Astera Labs by 12.5% in the first quarter. Illinois Municipal Retirement Fund now owns 5,455 shares of the company’s stock worth $598,000 after purchasing an additional 605 shares in the last quarter. Finally, Geneos Wealth Management Inc. raised its position in Astera Labs by 2.6% in the first quarter. Geneos Wealth Management Inc. now owns 8,055 shares of the company’s stock worth $883,000 after purchasing an additional 204 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Stock Down 10.8%

NASDAQ:ALAB opened at $291.58 on Friday. The firm has a market cap of $49.98 billion, a PE ratio of 197.01, a price-to-earnings-growth ratio of 3.38 and a beta of 3.66. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The company’s 50-day moving average price is $358.95 and its two-hundred day moving average price is $225.66.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the business posted $0.33 earnings per share. The company’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of Astera Labs stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $200.16, for a total value of $28,012,592.16. Following the completion of the transaction, the chief executive officer owned 3,929,183 shares of the company’s stock, valued at approximately $786,465,269.28. The trade was a 3.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,676,845 shares of company stock valued at $444,928,806 in the last three months. 10.40% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have commented on ALAB shares. Bank of America raised their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. JPMorgan Chase & Co. upped their price objective on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Barclays increased their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Needham & Company LLC raised their target price on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $282.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.